KIR3DL1 Interaction with HLA-B27 is altered by ankylosing spondylitis associated ERAP1 and enhanced by MHC class I cross-linking

Discovery Medicine

Volumn 20, Issue 108, 2015, Pages 79-89

  Abdullah, Hasan ^a   Zhang, Zhenbo ^b   Yee, Kirby ^c   Haroon, Nigil ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA B27 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; ERAP1 PROTEIN, HUMAN; KIR3DL1 PROTEIN, HUMAN;

ANKYLOSING SPONDYLITIS; ANTIBODY RESPONSE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; CAPPING PHENOMENON; CELL LINE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; PATHOLOGY;

AMINOPEPTIDASES; CELL LINE; GENE EXPRESSION REGULATION; HLA-B27 ANTIGEN; HUMANS; IMMUNOLOGIC CAPPING; KILLER CELLS, NATURAL; POLYMORPHISM, GENETIC; RECEPTORS, KIR3DL1; SPONDYLITIS, ANKYLOSING;

EID: 84940865827     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abdullah H, Haroon N. The role of endoplasmic reticulum aminopeptidase 1 (ERAP1) in Ankylosing Spondylitis. Ind J Rheumatol 9(1):14, 15-18, 2014.
2. Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 33(3):748-759, 2003.
3. Bodur H, Ataman S, Rezvani A, Budayci DS. Quality of life and related variables in patients with Ankylosing Spondylitis. Quality Life Res 20(4):543-549, 2011.
4. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 301(7809):904-907, 1973.
5. Brouwenstijn N, Serwold T, Shastri N. MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum. Immunity 15(1):95-104, 2001.
6. Burshtyn DN, Shin J, Stebbins C, Long EO. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Bio 10(13):777-780, 2000.
7. Burshtyn DN, Davidson C. Natural killer cell conjugate assay using two-color flow cytometry. Methods Mol Bio 612:89-96, 2010.
8. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39(11):1329-1337, 2007.
9. Chan AT, Kollnberger SD, Wedderburn LR, Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in Spondylarthritis. Arthritis Rheum 52(11):3586-3595, 2005.
10. Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105(12):4722-4729, 2005.
11. Evans DM, et al. Interaction between ERAP1 and HLA-B27 in Ankylosing Spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43(8):761-767, 2011.
12. Evnouchidou I, Kamal RP, Seregin SS, Goto Y, Tsujimoto M, Hattori A, Voulgari PV, Drosos AA, Amalfitano A, York IA, Stratikos E. Cutting Edge: Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 186(4):1909-1913, 2011.
13. Gran JT, Husby G, Hordvik M. Prevalence of Ankylosing Spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. Ann Rheum Dis 44(6):359-367, 1985.
14. Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A, Inman RD. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in Ankylosing Spondylitis. Ann Rheum Dis 71(4):589-595, 2012.
15. Hunter CA. New IL-12-Family Members: IL-23 and IL-27, Cytokines with divergent functions. Nat Rev Immunol 5(7):521-531, 2005.
16. Kollnberger S, Chan A, Sun M, Ye Chen L. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 Heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 37(5):1313-1322, 2007.
17. Martin-Esteban A, Gomez-Molina P, Sanz-Bravo A, Lopez de Castro JA. Combined effects of Ankylosing Spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands. J Biol Chem 289(7):3978-3990, 2014.
18. Nguyen TT, Chang SC, Evnouchidou I, York IA, Zikos C, Rock KL, Goldberg AL, Stratikos E, Stern LJ. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 18(5):604-613, 2011.
19. Ogasawara M, Kono DH, Yu DT. Mimicry of human histocompatibility HLA-B27 antigens by Klebsiella Pneumoniae. Infect Immun 51(3):901-908, 1986.
20. Peruzzi M, Parker KC, Long EO, Malnati MS. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol 157(8):3350-3356, 1996.
21. Rashid T, Ebringer A. Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. Autoimmune Dis 2012:539282, 2012.
22. Rashid T, Ebringer A. Gut-Mediated and HLA-B27-Associated Arthritis: An emphasis on Ankylosing Spondylitis and crohn's disease with a proposal for the use of new treatment. Discov Med 12(64):187-194, 2011.
23. Reeves E, Colebatch-Bourn A, Elliott T, Edwards CJ, James E. Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis. Proc Natl Acad Sci U S A 111(49):17594-17599, 2014.
24. Reeves E, Edwards CJ, Elliott T, James E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 191(1):35-43, 2013.
25. Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41-101, 2007.
26. Schwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with Ankylosing Spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella Pneumoniae as potential mechanism of autoimmune disease. J Exp Med 166(1):173-181, 1987.
27. Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA. Gene expression analysis of macrophages derived from Ankylosing Spondylitis patients reveals interferon-gamma dysregulation. Arthritis Rheum 58(6):1640-1649, 2008.
28. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 102(37):13224-13229, 2005.
29. Stone MA, Payne U, Schentag C, Rahman P, Pacheco-Tena C, Inman RD. Comparative Immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella Pneumonia in the pathogenesis of familial Ankylosing Spondylitis. Rheumatology (Oxford) 43(2):148-155, 2004.
30. Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, Bansal S, Ebringer A. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in japanese patients with Ankylosing Spondylitis and Rheumatoid Arthritis. J Rheumatol 24(1):109-114, 1997.
31. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 9(5):503-510, 2008.
32. Watzl C, Long EO. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to Lipid Rafts. J Exp Med 197(1):77-85, 2003.
33. Weisman MH, Reveille JD, Van Der Heijde D. Ch. 10: Epidemiology of Ankylosing Spondylitis and related Spondyloarthropathies. Ankylosing Spondylitis and the spondyloarthropathies. Mosby/Elsevier, pp117-131, 2006.
34. Zvyagin IV, Mamedov IZ, Britanova OV, Staroverov DB, Nasonov EL, Bochkova AG, Chkalina AV, Kotlobay AA, Korostin DO, Rebrikov DV, Lukyanov S, Lebedev YB, Chudakov DM. Contribution of functional KIR3DL1 to Ankylosing Spondylitis. Cell Mol Immunol 7(6):471-476, 2010.
35. van Bohemen CG, Grumet FC, Zanen HC. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology 52(4):607-610, 1984.
36. van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing Ankylosing Spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27(3):241-249, 1984.